Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib + Zevalin in Relapsed/Refractory Follicular Lymphoma
NCT00372905Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jul 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), transformed non-Hodgkin lymphoma, sponsored by Northwestern University. Started Jul 2007; status: terminated.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)transformed non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00372905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372905.